You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 9, September 2, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Venous Thromboembolism
 •Cardiovascular System
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antiphospholipid Syndrome, Microalbuminuria, and Risk of Venous Thromboembolism—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Mr Musallam and colleagues suggest that the association between microalbuminuria and VTE that we reported could have been confounded since adjustment for the presence of APS or high titers of aPLs was not performed. Antiphospholipid antibodies include lupus anticoagulants and anticardiolipin antibodies, among others. Lupus anticoagulants strongly correlate with VTE, whereas the association between anticardiolipin antibodies and VTE is disputed.1

Musallam et al mention that 20% of VTE cases are associated with high levels of aPLs, citing a review article that in turn refers to a study that investigated the association between anticardiolipin antibodies and VTE in a total of only 90 VTE cases.2 These results are in contrast with a large systematic review1 and 2 more recent and larger population-based prospective studies,3-4 in which no association was found between anticardiolipin antibodies and VTE. Therefore, it seems that either the 20% cited must have been part of a . . . [Full Text of this Article]

Bakhtawar K. Mahmoodi, BSc
b.k.mahmoodi@int.umcg.nl
Department of Hematology

Ron T. Gansevoort, MD, PhD
Department of Nephrology

Hanneke C. Kluin-Nelemans, MD, PhD
Department of Hematology
University Medical Center Groningen
Groningen, the Netherlands



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.